Tocqueville Asset Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,220
Closed -$167K 536
2023
Q2
$167K Sell
12,220
-1,630
-12% -$23.4K ﹤0.01% 514
2023
Q1
$212K Sell
13,850
-5,500
-28% -$84K ﹤0.01% 492
2022
Q4
$259K Sell
19,350
-152,450
-89% -$2.04M ﹤0.01% 515
2022
Q3
$2.28M Sell
171,800
-4,730
-3% -$81.7K 0.05% 267
2022
Q2
$3.38M Sell
176,530
-2,000
-1% -$37.9K 0.06% 254
2022
Q1
$3.56M Sell
178,530
-42,440
-19% -$857K 0.05% 278
2021
Q4
$4.51M Sell
220,970
-38,395
-15% -$820K 0.06% 269
2021
Q3
$5.59M Sell
259,365
-34,100
-12% -$821K 0.08% 231
2021
Q2
$8.47M Hold
293,465
0.12% 186
2021
Q1
$7.16M Sell
293,465
-3,800
-1% -$85.8K 0.11% 204
2020
Q4
$5.77M Buy
297,265
+75,550
+34% +$1.39M 0.1% 217
2020
Q3
$3.86M Buy
221,715
+72,475
+49% +$1.55M 0.07% 234
2020
Q2
$3.92M Sell
149,240
-30,095
-17% -$747K 0.08% 225
2020
Q1
$4.33M Sell
179,335
-102,386
-36% -$2.5M 0.11% 184
2019
Q4
$7M Buy
281,721
+5,405
+2% +$125K 0.1% 210
2019
Q3
$5.89M Buy
276,316
+214,708
+349% +$5.88M 0.08% 236
2019
Q2
$1.96M Buy
+61,608
New +$1.93M 0.03% 390

Other funds holding PAHC

Tocqueville Asset Management's PAHC Position: Q3 2023 in Review

Tocqueville Asset Management sold out of Phibro Animal Health (PAHC) in Q3 2023, closing a stake of 12,220 shares — an estimated $167K sold.

Tocqueville Asset Management first reported a position in PAHC in Q2 2019 and held it in 17 quarters. The position peaked at $8.47M in Q2 2021. 125 funds tracked by Wall St. Rank hold PAHC as of Q3 2023.

  • Tocqueville Asset Management reported no remaining Phibro Animal Health position as of Q3 2023 after selling out during the quarter.
  • Tocqueville Asset Management sold 12,220 Phibro Animal Health shares in Q3 2023, an estimated $167K.
  • Tocqueville Asset Management first reported a position in Phibro Animal Health in Q2 2019 and held it in 17 quarters.
  • Tocqueville Asset Management's Phibro Animal Health position peaked at $8.47M in Q2 2021.
  • 125 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2023.

Based on Tocqueville Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.